|
论晚期糖基化终产物与糖尿病血管病变 |
|
sion in ret
inal vascular endothelial cells is suppressed by high glucose and advanced glycation end products[J]. Diabetes, 1998,47(6):945-952. [8] Shoji T, Koyama H, Morioka T, et al. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes[J]. Diabetes,2006,55(8):2245-2255. [9] Renard C, Chappey O, Wautier MP, et al. Recombinant advanced glycation end product receptor pharmacokinetics in normal and diabetic rats[J]. Mol Pharmacol, 1997,52(1):54-62. [10] Wautier MP, Chappey O, Corda S, et al. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE[J]. Am J Physiol Endocrinol Metab,2001, 280(5):E685-E694. [11] 张卫茄,侯凡凡,刘尚喜,等. 晚期糖基化终产物增加动脉粥样硬化病变部位的炎症反应[J].中华肾脏病杂志,2005,21(6):360-363. [12] Bucala R,Vlassara H. Advanced glycosylation end products in diabetic renal and vascular disease[J]. Am J Kidney Dis,1995,26(6):875-888. [13] 张凯丽,李恩.糖基化作用与糖尿病肾脏并发症[J].国外医学·内分泌学分册,1999,19(3):122-124. [14] Makino H, Shikata K, Hironaka K, et al. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy[J]. Kidney Int,1995,48(2):517-526. [15] Pankewycz OG, Guan JX, Bolton WK, et al. Renal TGF-β regulation in spontaneously diabetic NOD mice with correlations in mesangial cells[J]. Kidney Int,1994,46(3):748-758. [16] 李硕. 糖尿病视网膜病变的发病机制及防治[J]. 广州医药, 2007,38(1):8-10. [17] Segawa Y, Shirao Y, Yamagishi S, et al. Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy[J]. Ophthalmic Res,1998,30(6): 333-339.
上一页 [1] [2] [3] [4] 上一个医学论文: 探讨外伤性截瘫患者的泌尿系管理 下一个医学论文: 探讨异丙嗪对曲马多镇痛作用的影响
|
|
|